Advertisement

Guide to Assessment Scales in Parkinson’s Disease

  • Pablo Martinez-Martin
  • Carmen Rodriguez-Blazquez
  • Maria João Forjaz
  • Kallol Ray Chaudhuri

Table of contents

  1. Front Matter
    Pages i-vi
  2. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 7-11
  3. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 13-23
  4. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 25-29
  5. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 31-42
  6. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 43-47
  7. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 49-65
  8. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 67-89
  9. Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz, Kallol Ray Chaudhuri
    Pages 91-102

About this book

Introduction

This Guide assesses the key clinimetric attributes in the assessment of Parkinson's Disease (PD), with the intention to offer rapid and pragmatic information on the most relevant scales used in PD. Parkinson’s disease affects approximately 4 million people globally and is most commonly seen in people over the age of 50. The disease is a progressive disorder of the nervous system, and presents a number of movement and cognitive symptoms, thereby greatly affecting a patients quality of life. The use of scales for assessment in neurological disorders such as PD arises from the need to quantify disorders and states (such constructs as disability, symptoms, quality of life). Assessment scales are often categorised into two categories: generic (i.e. those scales usable in any health condition), and specific (i.e. scales developed for exclusive use in PD). They can have a variety of components: single-item and multi-item or composite scale; unidimensional and multidimensional; and as disease-centered and patient-centered measures. The creation and validation of scales is complex, with scales undergoing numerous studies to assess criteria such as acceptability, reliability, and responsiveness. In the process of validation of a scale the following attributes should be tested to ascertain whether a scale is an effective instrument of measurement.

Keywords

Assesment scales Movement disorder Neurology Parkinson's disease Quality of life

Authors and affiliations

  • Pablo Martinez-Martin
    • 1
  • Carmen Rodriguez-Blazquez
    • 2
  • Maria João Forjaz
    • 3
  • Kallol Ray Chaudhuri
    • 4
  1. 1.Research unit, Alzheimer Centre Reina Sofia Foundation and Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Carlos III Institute of HealthMadridSpain
  2. 2.Area of Applied Epidemiology, National Centre for Epidemiology and Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Carlos III Institute of HealthMadridSpain
  3. 3.National School of Public Health and REDISSEC, Carlos III Institute of HealthMadridSpain
  4. 4.National Parkinson Foundation International Centre of Excellence, King’s College LondonLondonUnited Kingdom

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-907673-88-7
  • Copyright Information Springer Healthcare 2014
  • Publisher Name Springer Healthcare, Tarporley
  • eBook Packages Medicine
  • Print ISBN 978-1-907673-87-0
  • Online ISBN 978-1-907673-88-7
  • Buy this book on publisher's site
Industry Sectors
Pharma
Health & Hospitals
Biotechnology